Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$55.43

0.38 (0.69%)

16:12
10/09/16
10/09
16:12
10/09/16
16:12

Bristol-Myers reports final primary analysis of CheckMate-026 lung cancer study

Bristol-Myers Squibb announced the final primary analysis of CheckMate -026, a trial investigating the use of Opdivo monotherapy as first-line therapy in patients with advanced non-small cell lung cancer whose tumors expressed PD-L1 greater or equal to 1%. The study was powered to assess progression-free survival for patients with greater or equal to 5% PD-L1 expression. The topline results from the study were previously disclosed and showed CheckMate -026 did not meet the primary endpoint of superior PFS compared to chemotherapy. In patients with greater than/equal to 5% PD-L1 expression, the median PFS was 4.2 months with Opdivo and 5.9 months with platinum-based doublet chemotherapy. Overall survival was 14.4 months for Opdivo versus 13.2 months for chemotherapy, and 60% of patients on the chemotherapy arm received subsequent Opdivo use after progression either through crossover or commercial access. The safety of Opdivo was consistent with the known safety profile of the drug in previous studies. Among all-treated patients, treatment-related adverse events of any grade and Grade 3/4 occurred in 71% and 18% of Opdivo-treated patients and 92% and 51% of chemotherapy-treated patients, respectively.

  • 09

    Oct

  • 27

    Oct

  • 31

    Oct

  • 06

    Nov

BMY Bristol-Myers
$55.43

0.38 (0.69%)

09/12/16
JEFF
09/12/16
NO CHANGE
Target $57
JEFF
Hold
Jefferies cuts Bristol-Myers price target, upgrades AstraZeneca
Jefferies analyst Jeffrey Holford lowered his price target for Bristol-Myers Squibb (BMY) to $57 from $69 saying the stock is positioned for a "rough mid term ride." The analyst sees a "difficult catalyst" set for Bristol shares with "numerous" upcoming competitor read-outs in non-small cell lung cancer. The market could see worse than expected data from Bristol's CM-026 and CM-568 studies as well as better than expected data from AstraZeneca's (AZN) MYSTIC study and Roche's (RHHBY) Chemo-IO studies in the first half of 2017, Holford tells investors in a research note. He keeps a Hold rating on Bristol and upgraded this morning AstraZeneca to Buy from Hold. Holford prefers Astra for its immunology exposure.
09/20/16
SBSH
09/20/16
NO CHANGE
Target $70
SBSH
Buy
Bristol-Myers price target lowered to $70 from $75 at Citi
In a research note titled "Brace Yourself. Attractive Valuation but No Near-Term Respite.," Citi analyst Andrew Baum lowered his price target for shares of Bristol-Myers Squibb to $70 from $75. The analyst lowered his earnings forecasts by up to 8% to reflect the "limited supportive data" in the non-small cell lung cancer indication. Baum keeps a Buy rating on the shares as he views the valuation as attractive. He points out, however, the near-term news-flow is likely to be negative.
09/27/16
PIPR
09/27/16
NO CHANGE
Target $62
PIPR
Neutral
Bristol-Myers price target lowered to $62 from $65 at Piper Jaffray
Piper Jaffray analyst Richard Purkiss lowered his price target for Bristol-Myers Squibb (BMY) to $62 saying he sees the company ceding Opdivo's early-mover advantage in lung cancer to competitors. The analyst expects to see details from Roche's (RHHBY) positive OAK trial of Tecentriq vs. docetaxel in non-small cell lung cancer at the upcoming ESMO meeting. Purkiss also expects to see details from Merck's (MRK) positive KEYNOTE-024 trial of Keytruda. The analyst lowered his post-2016 Opdivo forecasts and reiterates a Neutral rating on Bristol shares.
09/28/16
ROTH
09/28/16
NO CHANGE
Target $23
ROTH
Buy
Nektar price target raised to $23 from $19 at Roth Capital
Roth Capital analyst Michael Higgins raised his price target for Nektar (NKTR) to $23 from $19 after the company and Bristol-Myers (BMY) announced a clinical collaboration to evaluate the combination of the latter's anti-PD-1 antibody, Opdivo, with NKTR-214. The analyst reiterates a Buy rating on Nektar's shares.

TODAY'S FREE FLY STORIES

ED

Consolidated Edison

$78.74

-0.535 (-0.67%)

14:45
01/18/18
01/18
14:45
01/18/18
14:45
Hot Stocks
Consolidated Edison boosts quarterly dividend to 71.5c per share »

Consolidated Edison…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$84.00

-0.425 (-0.50%)

14:43
01/18/18
01/18
14:43
01/18/18
14:43
Periodicals
SoftBank closes $1.2B deal to invest in Uber, TechCrunch says »

SoftBank's $1.2B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FE

FirstEnergy

$29.73

-0.195 (-0.65%)

14:31
01/18/18
01/18
14:31
01/18/18
14:31
Conference/Events
FirstEnergy participates in a webcast with Wolfe Research »

Utilities Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

COG

Cabot Oil & Gas

$27.76

-0.225 (-0.80%)

14:30
01/18/18
01/18
14:30
01/18/18
14:30
Options
Notable call buying in Cabot Oil and Gas »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:30
01/18/18
01/18
14:30
01/18/18
14:30
General news
Canada manufacturing preview »

Canada manufacturing…

14:28
01/18/18
01/18
14:28
01/18/18
14:28
Conference/Events
Wolfe Research airlines/A&D analyst holds an analyst/industry conference call »

Airlines and Aerospace…

IIIN

Insteel

$29.83

0.57 (1.95%)

14:27
01/18/18
01/18
14:27
01/18/18
14:27
Downgrade
Insteel rating change  »

Insteel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

URI

United Rentals

$181.44

1.27 (0.70%)

14:25
01/18/18
01/18
14:25
01/18/18
14:25
Options
United Rentals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

XLK

Technology Select Sector SPDR

$67.80

0.25 (0.37%)

, XLF

Financial Select Sector

$29.41

0.04 (0.14%)

14:17
01/18/18
01/18
14:17
01/18/18
14:17
Technical Analysis
Technical Take: S&P 500 turns positive, bullish intraday pattern active »

The S&P 500 (SPX) has…

XLK

Technology Select Sector SPDR

$67.80

0.25 (0.37%)

XLF

Financial Select Sector

$29.41

0.04 (0.14%)

XLE

Energy Select Sector SPDR

$76.83

-0.28 (-0.36%)

XLV

Health Care Select Sector SPDR

$87.91

-0.18 (-0.20%)

SPY

SPDR S&P 500 ETF Trust

$279.59

-0.02 (-0.01%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
01/18/18
01/18
14:17
01/18/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
01/18/18
01/18
14:16
01/18/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADT

ADT Inc.

, APO

Apollo Global

$35.12

-0.3 (-0.85%)

14:14
01/18/18
01/18
14:14
01/18/18
14:14
Syndicate
ADT Inc. IPO likely to price below $17-$19 range, WSJ reports »

ADT's (ADT) initial…

ADT

ADT Inc.

APO

Apollo Global

$35.12

-0.3 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 19

    Jan

FB

Facebook

$177.60

-0.79 (-0.44%)

, AXP

American Express

$100.17

-0.59 (-0.59%)

14:12
01/18/18
01/18
14:12
01/18/18
14:12
Hot Stocks
Facebook appoints American Expres CEO Chenault to board »

Facebook (FB) announced…

FB

Facebook

$177.60

-0.79 (-0.44%)

AXP

American Express

$100.17

-0.59 (-0.59%)

IBM

IBM

$169.03

0.38 (0.23%)

PG

Procter & Gamble

$90.28

-0.2304 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 23

    Jan

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 16

    Feb

  • 28

    Feb

TTWO

Take-Two

$116.09

2.13 (1.87%)

14:05
01/18/18
01/18
14:05
01/18/18
14:05
Options
TakeTwo Interactive Software call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

MGNX

MacroGenics

$19.85

0.07 (0.35%)

14:01
01/18/18
01/18
14:01
01/18/18
14:01
Hot Stocks
MacroGenics 'encouraged' by sudy of margetuximab plus pembrolizumab »

MacroGenics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

13:55
01/18/18
01/18
13:55
01/18/18
13:55
Conference/Events
House Homeland Security Committee to hold a hearing »

The Transportation and…

QEP

QEP Resources

$10.93

-0.04 (-0.36%)

13:55
01/18/18
01/18
13:55
01/18/18
13:55
Conference/Events
House Committee on Natural Resources to hold an oversight hearing »

The Subcommittee on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

JAGX

Jaguar Health

$0.14

0.002 (1.43%)

13:53
01/18/18
01/18
13:53
01/18/18
13:53
Conference/Events
Jaguar Health to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTCT

PTC Therapeutics

$21.95

0.46 (2.14%)

13:51
01/18/18
01/18
13:51
01/18/18
13:51
Periodicals
PTC raised price of muscular-dystrophy drug by 9%, WSJ reports »

PTC Therapeutics raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTX

Manitex

$9.63

0.11 (1.16%)

13:48
01/18/18
01/18
13:48
01/18/18
13:48
Hot Stocks
Manitex announces $6.3M order for cranes »

Manitex International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMNY

Helios and Matheson

$7.73

-0.43 (-5.27%)

13:45
01/18/18
01/18
13:45
01/18/18
13:45
Options
Helios and Matheson call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

13:41
01/18/18
01/18
13:41
01/18/18
13:41
Periodicals
Amazon sends team to Israel to determine market conditions, Globes reports »

Amazon sent a team to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 19

    Jan

  • 18

    Mar

DB

Deutsche Bank

$18.57

0.05 (0.27%)

13:33
01/18/18
01/18
13:33
01/18/18
13:33
Periodicals
Cryan says Deutsche Bank in 'third phase' of turnaround, Bloomberg reports »

Deutsche Bank CEO John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FMC

FMC Corporation

$89.31

-4.55 (-4.85%)

, ALB

Albemarle

$117.89

-9.065 (-7.14%)

13:32
01/18/18
01/18
13:32
01/18/18
13:32
Hot Stocks
Lithium producers get crushed after Chile regulator rules on SQM »

Shares of lithium…

FMC

FMC Corporation

$89.31

-4.55 (-4.85%)

ALB

Albemarle

$117.89

-9.065 (-7.14%)

SQM

SQM

$58.29

-1.26 (-2.12%)

TSLA

Tesla

$347.16

7.1 (2.09%)

F

Ford

$12.09

-0.09 (-0.74%)

TM

Toyota

$138.70

-2.02 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 13

    Feb

  • 28

    Feb

  • 07

    Mar

SLB

Schlumberger

$77.02

-0.195 (-0.25%)

13:31
01/18/18
01/18
13:31
01/18/18
13:31
Technical Analysis
Technical Earnings Preview: Schlumberger has a potential bullish pattern »

On the 1-year daily…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.